EFPIA - NEWSLETTER

EFPIA Newsletter 28 May 2020

#WeWontRest in the fight against COVID-19

27 May 2020 Resilience and recovery: EFPIA response to the publication of the EU recovery plan

We very much welcome the Commission’s commitment to resilience and recovery, in particular the inclusion of the new...

Blogs

28 May 2020 What I have learned from the pandemic and why connections are so important

Brigit has been living with Multiple Sclerosis for more than 15 years now and, as many other patients, was not prepared...

25 May 2020 Shoulder to shoulder with patients with bladder cancer during times of pandemic

Raising awareness about bladder cancer and treatment options while promoting collaborative approaches and support to...

25 May 2020 May is when we come together to help the world get more #BladderCancerAware

COVID-19 confronts us with new challenges and amplifies the existing ones. Neither should be overlooked, if we are to...

25 May 2020 Bladder Cancer Awareness Month: reaffirming our commitment to people living with bladder cancer...

There is still so much more to do, and so I’m standing with all of those affected by this disease and assuring them...

25 May 2020 ECPC Awareness Campaign on Merkel Cell Carcinoma

Prevention is much easier than a cure, please help us spreading awareness of this rare and aggressive disease to a wider...

Videos

Europe’s COVID-19 battle: ensuring the supply of medicines to the patients that need them

EFPIA member companies are working around the clock to increase capacity and ensure supply of critical medicines to patients across Europe

#WeWontRest until there is a COVID-19 vaccine for everyone

The research-based pharmaceutical industry is working around the clock at extraordinary speed to develop a safe and effective vaccine against COVID-19 to protect people from future outbreaks

Cancer and COVID-19 | Looking Past the Pandemic: Cancer care for 2022 and Beyond

The third virtual event focusing on the impact of COVID-19 on cancer care was held on 18 May 2020.

Clinical Trials at the time of COVID-19: And beyond?

COVID-19 has been a catalyst in optimising research and development and streamlining regulatory processes. Some of the elements that in the context of COVID-19 have simplified procedures, minimised non-value adding activities and accelerated delivery, should be evaluated and tested to help us address health challenges.

Our next #EFPIATalks

09 JUN 2020

United in the search of a COVID-19 vaccine Virtual event

The first of a series of virtual events dedicated on COVID-19 vaccines and pandemic preparedness

Learn more →

11 JUN 2020

Diabetes and COVID-19: when two pandemics meet - Integrated care Virtual event

Rethinking health systems: integrated care and empowerment of primary care

Learn more →

What we are reading

COVID-19 - Leaving no-one behind, now and in the future. How Europe can emerge from the crisis... 27 May 2020 (Patient Access Partnership)

The EU Health Coalition calls for Health Ministers to keep a key role in the EU Recovery Instrument... 27 May 2020 (EU Health Coalition)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶